Hyundai E&C and Woojin: Where Is the Asymmetric Bargaining Power in U.S. Nuclear Expansion?

Context This is a follow-up to Korea’s $350bn U.S. investment law: what is the nuclear opportunity for Team Korea?. Related reads: ETF flow is leading the Korean market, HD Hyundai Heavy Industries’ SMR option, U.S. non-semiconductor rerating into Korea, and the Exclusive Analysis Hub.

TL;DR

• U.S. nuclear momentum is real. DOE has reiterated the goal of expanding U.S. nuclear capacity from about 100GW today toward 400GW by 2050, while the White House has pushed NRC reform and faster reactor decisions.
• Do not buy “Korea nuclear” as one undifferentiated basket. For U.S. nuclear expansion, business directness looks like Hyundai E&C > Doosan Enerbility > Woojin > Daewoo E&C. But stock attractiveness depends on price, flow, and bargaining power.
• Hyundai E&C is the most direct Korean equity here. It is tied to Fermi’s four-unit AP1000 FEED path and Holtec’s SMR-300/Palisades/10GW fleet narrative. Its bargaining power is not reactor IP. It is the U.S. shortage of proven nuclear EPC and project-management execution.
• Woojin is smaller and more asymmetric. Its base case is Korea-native nuclear instrumentation, ICI replacement demand, and RSPT/RTD references. Direct U.S. AP1000 adoption is not publicly confirmed. Treat that as an option, not the base case.
• Entry discipline: Hyundai E&C is Pullback Buy, Woojin is small Conditional Buy, Doosan Enerbility is Wait, and Daewoo E&C is Avoid for this specific thesis.

1. Why This Follow-Up Matters

The previous note framed Korea’s $350bn U.S. investment plan as policy capital, not an automatic order book for Korean companies. That distinction matters even more for nuclear.

The structure is closer to:

The nuclear value chain therefore needs to be broken into nodes:

Hyundai E&C and Woojin sit in different nodes. Hyundai E&C is the EPC/PMO execution name. Woojin is the instrumentation and recurring-replacement option.

2. U.S. Nuclear Momentum Is Real

DOE’s May 2026 update described U.S. nuclear momentum across Gen III+ SMRs, TerraPower Natrium, Palisades restart, uprates and AI-related power demand. The policy objective is to expand U.S. nuclear capacity from roughly 100GW to 400GW by 2050. (U.S. DOE)

The White House NRC reform order points to faster review clocks, including final decisions on new reactor construction and operation applications within no more than 18 months. (White House)

Project evidence is also visible:

Fermi America describes Project Matador as a large energy campus for AI, data centers and advanced manufacturing, with four AP1000 units and a strategic Hyundai E&C partnership. (Fermi America)

The NRC page confirms that Fermi submitted a combined license application for AP1000 Units 1-4, that two of three parts have been submitted, and that NRC review is underway. (NRC)

World Nuclear News reported Holtec’s Palisades SMR-300 plan and the expanded construction agreement with Hyundai E&C, with a 10GW North American SMR-300 fleet target. (World Nuclear News)

3. Hyundai E&C: The Most Direct Korean Execution Name

Hyundai E&C is not a reactor-IP owner. It does not own AP1000, SMR-300 or Natrium. Its value is different: it is one of the few Korean companies with credible nuclear construction, site execution and large-project PMO credentials.

Fermi AP1000

Fermi gives Hyundai E&C the cleanest direct U.S. nuclear exposure. The company is tied to FEED work for four AP1000 units in Texas. That does not yet equal a full EPC revenue contract, but it is a real channel.

Holtec SMR-300

Holtec may be the more asymmetric channel. Palisades is the first visible project, but the 10GW fleet ambition matters more.

Simple math:

If Palisades works, Hyundai E&C is not just a one-project beneficiary. It could become a repeat-build execution partner.

Where Hyundai’s Bargaining Power Comes From

U.S. nuclear expansion is not only a technology problem. It is also a build problem. The market needs firms that can manage nuclear QA, civil construction, schedule discipline, BOP integration, documentation and local supply-chain complexity.

Hyundai E&C’s experience with Barakah, Shin Hanul and large global infrastructure does not guarantee U.S. economics. But it gives the company a credible seat at the table.

The main risk is contract structure:

For Hyundai, the key evidence is FEED-to-EPC conversion, scope, risk sharing and whether Holtec fleet economics become repeatable.

4. Woojin: The Smaller Instrumentation Option

Woojin is a very different setup. It is not an EPC company. It is a nuclear instrumentation and sensor company.

The base case is:

1. Korea-native nuclear instrumentation references
2. ICI recurring replacement demand
3. RSPT, RTD and other safety-related measurement products
4. U.S. SMR/AP1000 adoption as an unconfirmed option

Woojin’s 1Q26 numbers improved sharply. Edaily Marketin reported 1Q26 revenue of KRW 37.2bn, up 36.9% YoY, and operating profit of KRW 5.0bn, turning positive. Operating margin was about 13.4%. (Edaily Marketin)

Bloter reported that Woojin’s nuclear-equipment revenue rose to KRW 12.2bn, up 60.8% YoY, while nuclear operating profit rose to KRW 3.0bn from KRW 0.3bn. The temperature-sensor and instrumentation segment also rose 43.5% YoY. (Bloter via Daum)

Woojin’s product map matters:

Woojin signed a KRW 6.4bn RSPT contract with Doosan Enerbility for Shin Hanul 3/4. (Edaily Marketin)

It also disclosed a KRW 8.27bn ICI contract for standard nuclear-plant overhaul demand, equal to about 5.88% of recent revenue. (Hankyung via Daum)

The important caveat: there is no public confirmation that Woojin is directly adopted in U.S. AP1000 projects. Westinghouse has its own qualified supply chain, and U.S. nuclear instrumentation has high QA, environmental and seismic qualification barriers. Woojin’s Korean APR1400 references do not automatically transfer to AP1000.

So the correct framing is:

Woojin is a Korea-native nuclear instrumentation moat with a U.S. optionality layer, not a confirmed AP1000 supplier.

5. Hyundai E&C vs Woojin

Hyundai E&C has more direct business exposure. Woojin has more small-cap convexity.

6. Why Doosan and Daewoo Are Lower Priority Here

Doosan Enerbility is strategically important. It sits in large equipment, NuScale, TerraPower and X-energy supply-chain conversations. But as a stock, the optionality is already large, valuation is demanding, and recent foreign flow is still weak. The correct posture is Wait, not chase.

Daewoo E&C has Czech nuclear and Team Korea relevance, but its direct U.S. nuclear exposure is weaker than Hyundai E&C’s. It may trade as nuclear beta, but it is not the clean expression of this U.S. thesis.

7. Entry Screen

Internal price and flow data as of the June 12, 2026 close:

Final View

If choosing one name, it is Hyundai E&C. It is the cleanest Korean equity for U.S. nuclear development exposure. But after a 5-day 19.4% move, buying the pullback is better than chasing.

If taking a small asymmetric position, Woojin is the candidate. The price has cooled, but the U.S. AP1000 angle is unverified. Treat it as a sub-1% pilot option, not a core position.

Doosan is the right strategic company but currently a rich option. Daewoo is not the clean U.S. nuclear expression.

Evidence Ledger